NCT07548476
- Conditions
- Advanced Urothelial Cancer, Bladder Cancer, Female Urogenital Diseases, +17 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Metastatic Bladder Cancer
Explore clinical trials studying Metastatic Bladder Cancer. Study availability and eligibility vary by location and protocol.
9 public trials
2 recruiting studies
Metastatic Bladder Cancer trial results
NCT06138561
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, not recruiting
A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer
NCT02989584
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +15 more
- Locations
-
- Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
Active, not recruiting
A Study to Compare the Results of FGFR Testing by Either ctDNA Blood Testing or Standard Tumor Tissue Testing
NCT06129084
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +14 more
- Locations
-
- Arthur J.E Child Comprehensive Cancer Centre Calgary, Alberta, Canada
- Cross Cancer Institute Edmonton, Alberta, Canada
- BC Cancer Agency Vancouver, British Columbia, Canada
- London Health Sciences Centre London, Ontario, Canada
NCT04200963
- Conditions
- Advanced Cancer, Advanced Solid Tumor, Bladder Cancer, +35 more
- Locations
-
- Banner Health- MD Anderson Cancer Center Gilbert, Arizona, United States
- Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
- Rush University Medical Center Chicago, Illinois, United States
- Johns Hopkins Kimmel Cancer Center Baltimore, Maryland, United States
NCT02030067
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +14 more
- Locations
-
- Rexahn Site Birmingham, Alabama, United States
- Rexahn Site Tucson, Arizona, United States
- Rexahn Site Duarte, California, United States
- Rexahn Site Miami, Florida, United States
NCT03430895
- Conditions
- Adenocarcinoma of the Bladder, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Commack Commack, New York, United States
- Memoral Sloan Kettering Westchester Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
Completed
Phase I / II Study of Enadenotucirev by Sub-acute Fractionated IV Dosing in Cancer Patients
NCT02028442
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +20 more
- Locations
-
- GZA ziekenhuizen campus Sint-Augustinus Wilrijk, Antwerp, Belgium
- Cliniques Universitaires St Luc Brussels, Belgium
- Ghent University Hospital Ghent, Belgium
- Institut Catala d Oncologica Barcelona, Spain
NCT01454089
- Conditions
- Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +14 more
- Locations
-
- City of Hope National Medical Center Duarte, California, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- University of California Los Angeles Los Angeles, California, United States
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States